“If you have ovarian cancer, ask your oncologist to consider a test that will help determine whether your cancer is one of just under 50 per cent that might be responsive to new treatment options such as PARP inhibitors," says cancer researcher Professor Anna deFazio. …
If you have ovarian cancer, genomic testing may open up new treatment option
December 18, 2024 BioPharmaAustralian Biotech
Latest Video
New Stories
-
Race Oncology appoints Opthea founder to its board
December 18, 2024 - - Australian Biotech -
New listings and higher prescription volumes driving PBS spend
December 18, 2024 - - Latest News -
If you have ovarian cancer, genomic testing may open up new treatment option
December 18, 2024 - - BioPharma -
Cartherics secures G-Rex grant to support its ‘in house’ manufacturing program
December 18, 2024 - - Australian Biotech -
Researchers say Australia’s first mRNA vaccine candidate could address COVID ‘immune imprinting’
December 18, 2024 - - Australian Biotech -
Government making it easier for itself on Safety Net but patients missing out
December 18, 2024 - - Latest News -
HTA implementation group waiting for ministerial direction on priorities
December 18, 2024 - - Latest News